IRIS
CIRIONI, Oscar
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.111
EU - Europa 4.609
AS - Asia 1.674
AF - Africa 177
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 7
OC - Oceania 5
Totale 15.593
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.086
UA - Ucraina 1.188
IE - Irlanda 681
SE - Svezia 653
IT - Italia 608
TR - Turchia 553
DE - Germania 514
SG - Singapore 437
DK - Danimarca 435
CN - Cina 375
FI - Finlandia 250
KR - Corea 238
CI - Costa d'Avorio 160
GB - Regno Unito 145
FR - Francia 47
IR - Iran 27
IN - India 26
CA - Canada 23
BE - Belgio 22
MA - Marocco 17
RU - Federazione Russa 17
NL - Olanda 16
EU - Europa 8
RO - Romania 8
PK - Pakistan 7
AT - Austria 5
BG - Bulgaria 5
TH - Thailandia 5
AU - Australia 4
CL - Cile 4
PL - Polonia 4
CH - Svizzera 3
JP - Giappone 3
A1 - Anonimo 2
HK - Hong Kong 2
HR - Croazia 2
MX - Messico 2
RS - Serbia 2
AR - Argentina 1
BR - Brasile 1
CZ - Repubblica Ceca 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
VE - Venezuela 1
Totale 15.593
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.214
Chandler 1.067
Fairfield 840
Dublin 671
Boardman 626
Ashburn 505
Wilmington 494
Woodbridge 403
Ann Arbor 313
New York 309
Houston 302
Seattle 291
Des Moines 290
Lawrence 257
Princeton 257
Cambridge 251
San Mateo 249
Abidjan 160
Singapore 135
San Diego 121
Turin 111
Centro 95
Beijing 62
Redmond 59
Guangzhou 34
Shanghai 34
London 29
Izmir 28
Norwalk 28
Washington 27
Helsinki 24
Los Angeles 24
Marche 23
Brussels 22
Falls Church 22
Wuhan 22
Porto 20
Ancona 19
Dallas 15
Jiaxing 15
Kilburn 15
Ottawa 15
Cingoli 14
Pune 14
Wuxi 13
Moscow 11
Rome 10
North Bergen 9
Dronten 8
Prescot 8
Buffalo 7
Nanjing 7
Seoul 7
Chiswick 6
Jesi 6
New Bedfont 6
Pergola 6
Pesaro 6
San Benedetto del Tronto 6
Acton 5
Bangkok 5
Civitanova Marche 5
Shenzhen 5
Tolentino 5
Amsterdam 4
Auburn Hills 4
Boydton 4
Campobasso 4
Clifton 4
Dalian 4
Hanover 4
Jinhua 4
Macerata 4
Milan 4
Napoli 4
Rahim Yar Khan 4
San Severino Marche 4
Squinzano 4
Vallefoglia 4
Venice 4
Vienna 4
Yiwu 4
Appignano 3
Breda Di Piave 3
Chiaravalle 3
Chizhou 3
Delhi 3
Fayetteville 3
Fort Worth 3
Gdansk 3
Heze 3
Hounslow 3
Palermo 3
San Jose 3
Serra 3
Toronto 3
Zibo 3
Zurich 3
Adelaide 2
Arco 2
Totale 9.791
Salva come PNG Salva come JPEG
Nome #
Antimicrobial Resistance: A Challenge for the Future 157
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 129
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 129
Enhanced efficacy of combinations of pexiganan with colistin versus Acinetobacter baumannii in experimental sepsis 116
Characterization of a new transferable MDR plasmid carrying the pbp5 gene from a clade B commensal Enterococcus faecium 115
Efficacy of the quorum sensing inhibitor FS10 alone and in combination with tigecycline in an animal model of staphylococcal infected wound 114
Anticryptosporidial activity of paromomycin. 108
Characterization of a Multiresistance Plasmid Carrying the optrA and cfr Resistance Genes From an Enterococcus faecium Clinical Isolate 107
Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis. 103
Protective effects of the combination alpha-helical antimicrobial peptides and rifampin in three rat models of Pseudomonas aeruginosa infection 101
Tachyplesin III and Granulocyte-Colony Stimulating Factor Enhance the Efficacy of Piperacillin/Tazobactam in a Neutropenic Mouse Model of Polymicrobial Peritonitis 98
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture. 98
Tigecycline accelerates staphylococcal infected burn wound helaing through MMP-9 modlualtion 96
Antimicrobial activity of polycationic peptides 95
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 92
In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp. 91
Spread of colistin resistance gene mcr-1 in Italy: characterization of the mcr-1.2 allelic variant in a colistin-resistant blood isolate of Escherichia coli 91
In-vitro effect of short-term exposure to two synthetic peptides, alone or in combination with clarithromycin or rifabutin, on Cryptosporidium parvum infectivity. 89
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 89
Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture. 88
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 86
Effects of the Infusion of 4% or 20% Human Serum Albumin on the Skeletal Muscle Microcirculation in Endotoxemic Rats 86
null 86
Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis 85
Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds. 85
Rate and determinants of residual viremia in multidrug-experienced patients successfully treated with raltegravir-based regimens 85
Efficacy of pexiganan combination with tigecycline in a mouse model of Pseudomonas aeruginosa sepsis 85
High rate of ceftobiprole resistance among clinical methicillin-resistant Staphylococcus aureus isolates from a hospital in central Italy 83
Suppression of biofilm related, device-associated infections by staphylococcal quorum sensing inhibitors. 82
The Antimicrobial Peptide Tachyplesin III Coated alone and in Combination with Intraperitoneal Piperacillin-Tazobactam Prevents Ureteral Stent Biofilm Formation in a Rat Subcutaneous Pouch Model of Pseudomonas Infection. 82
Epidemiology and microbiology of surgical wound infections. 82
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 82
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 81
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 81
In vitro activity of Protegrin-1, alone and in combination with clinically useful antibiotics, against Acinetobacter baumannii strains isolated from surgical wounds 81
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 81
Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant Escherichia coli isolates 80
In-vitro activity of rifabutin and albendazolo singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii. 79
The antimicrobial peptide Tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model 79
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 78
In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH(2) alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans. 77
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. 77
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 77
In vitro and in vivo activity of aurintricarboxylic acid preparations against Cryptosporidium parvum. 77
Urinary catheters and biofilm formation 77
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 76
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 75
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection 74
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 74
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 74
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Grampositive cocci isolated from surgical wound infections 74
Delayed wound healing in aged skin rat models after thermal injury is associated with an increased MMP-9, K6 and CD44 expression 73
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 72
OpuC--an ABC transporter that is associated with Staphylococcus aureus pathogenesis. 72
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 72
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 71
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 71
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. 71
Interindividual and intra-individual variabilities of Darunavir and Ritonavir plasma trough concentrations in multidrug experienced HIV patients receiving salvage regimens. 71
RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus. 71
Role of daptomycin on burn wound healing in an animal methicillin-resistant staphylococcus aureus infection model 71
Vitamin E supplementation in old mice induces antimicrobial activity and improves the efficacy of daptomycin in an animal model of wounds infected with methicillin resistant Staphylococcus aureus. 70
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 70
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. 70
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 70
Review: A safety profile of dalbavancin for onand off-label utilization 70
Quorum Sensing Inhibitor FS3-coated Vascular Graft Enhances Daptomycin Efficacy in a Rat Model of Staphylococcal Biofilm Infection. 70
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 69
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 69
In- vitro activity of terbinafine, atovaquone and co-trimoxazole against Pneumocystis carinii. 69
The efficacy of the quorum sensing inhibitor FS8 and tigecycline in preventing prosthesis biofilm in an animal model of staphylococcal infection 69
Viscoelastic behaviour of hyaluronic acid formulations containing carvacrol prodrugs with antibacterial properties 69
whISOBAX™ inhibits bacterial pathogenesis and enhances the effect of antibiotics 69
Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in a animal model of ureteral stent infection. 68
In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics. 68
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 68
In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes 68
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 68
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 68
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents. 68
Antimicrobial Activity of Different Antimicrobial Peptides (AMPs) Against Clinical Methicillin-resistant Staphylococcus aureus (MRSA) 68
Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection. 67
Durability and tolerability of long-term nevirapine-based HAART. 67
In vitro activity of the lipopeptide derivative (Pal-Lys-Lys-NH), alone and in combination with antifungal agents, against clinical isolates of dermatophytes. 67
In-vitro activity of polycationic peptides against Cryptosporidium parvum, Pneumocystis carinii and yeast clinical isolates. 67
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa. 67
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 67
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 67
In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics. 66
Antimicrobial peptides (Temporin A and Iseganan IB-367): effect on the cysticerci of Taenia crassiceps. 66
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide 66
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 66
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 66
Effect of omiganan on colonic anastomosis healing in a rat model of peritonitis 65
Efficacy of LL-37 and Granulocyte-Colony Stimulating Factor in a Neutropenic Murine Sepsis due to Pseudomonas aeruginosa 64
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 64
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 64
A In vitro and in vivo activity of aurintricarboxylic acid against Cryptosporidium parvum 64
In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients. 63
S-thanatin enhances the efficacy of tigecycline in an experimental rat model of polymicrobial peritonitis. 63
Totale 7.926
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.228
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.228
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.485 0 0 245 7 249 11 254 8 252 54 50 355
2020/20213.635 186 389 497 50 395 233 372 226 367 369 378 173
2021/20222.043 132 450 13 106 33 147 92 118 142 267 133 410
2022/20233.528 350 340 257 251 267 547 7 186 896 18 277 132
2023/20242.007 368 49 135 324 350 419 34 55 22 27 26 198
2024/2025897 568 329 0 0 0 0 0 0 0 0 0 0
Totale 15.909